Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
How is 'A Knight of the Seven Kingdoms' connected to 'Game of Thrones'? - 2FDA proposes use of sunscreen ingredient popular in other countries
- 3Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
- 4A definitive Manual for the 5 Off-road Bicycles Available
- 5The most effective method to Succeed in Your Web based Advertising Degree: Procedures for Progress
- 7 Fun Plans to Make Film Evenings Seriously Invigorating (You'll Cherish #5!)
- Move. Cheer. Dance. Do the wave. How to tap into the collective joy of 'we mode'
- Stop the ‘good’ vs ‘bad’ snap judgments and watch your world become more interesting
- Court clears Beersheba assault suspect of link to Haymanut Kasau disappearance, extends detention
- What do scientists hope to learn from NASA's historic Artemis 2 moon flyby?
- The 15 Most Motivating TED Discusses All Time
- Philippines evacuates 3,000 villagers after volcano activity raises alert level
- Barry Manilow to have surgery for early-stage lung cancer and postpones January concerts
- Rights group: At least 2,500 deaths during protest crackdown in Iran
